Alignment Healthcare cut to neutral from buy at BofA Global Research; price objective cut to $9 from $25
ALHC•BofA Global Research cut its rating on Alignment Healthcare to neutral from buy and lowered its price objective to $9 from $25.
Related News
French and Italian debt risk premiums set for weekly decline
TLT•
Delta Air Lines posts transcript of 3Q26 earnings call
DAL•
Trump launches committee to probe Fed's Lisa Cook, White House says
TLT•
Prothena 10% owner William P. Scully reports $1,820,946 purchase of common shares
PRTA•
Banco Bradesco director Rubens Aguiar Alvarez reports BRL 31.26 million common-share purchase
BBD•